Skip to content
Use caution Drug recall · FDA · Published April 13, 2012

West-Ward Recalls Fosphenytoin Sodium Injection Due to Particulate Matter

West-Ward Pharmaceutical recalls Fosphenytoin Sodium Injection vials due to particulate matter. Check lot numbers and expiration dates for affected batches.

🇺🇸 FDA recall #D-1438-2012DrugWest-Ward ›
Take action

Contact the company

Recalling firmWest-ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

West-Ward Pharmaceutical Corp. is recalling Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL single-dose vials because particles were found in stability and retain samples. The recall covers multiple lots distributed throughout the US with expiration dates ranging from May 2012 to November 2013. No specific remedy or action steps are currently stated in the record. Read more at govinfonow.com/recall/48929-west-ward-pharmaceutical-corp-recalls-fosphenytoin-sodium-injection-usp-500.

Source Summary by GovInfoNow · govinfonow.com/recall/48929-west-ward-pharmaceutical-corp-recalls-fosphenytoin-sodium-injection-usp-500 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1438-2012

Cite this page

“West-Ward Recalls Fosphenytoin Sodium Injection Due to Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48929-west-ward-pharmaceutical-corp-recalls-fosphenytoin-sodium-injection-usp-500. Based on FDA recall #D-1438-2012 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1438-2012%22&limit=1).

The FDA announced on April 13, 2012, that West-Ward Pharmaceutical Corp. is recalling Fosphenytoin Sodium Injection due to the presence of particulate matter. The recall involves products distributed throughout the United States.

How to tell if you have it

  • West-Ward brand
  • NOVAPLUS brand
  • Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10 mL Single Dose Vial
  • NDC 0143-9703-10
  • NDC 0143-9782-10
  • Lot #s: 112161.1, 112162.1, 112163.1 (Exp 05/13); 102165.2, 102167.1 (Exp 05/12); 102190.1, 102191.1, 102191.2, 102192.1, 102213.1 (Exp 07/12); 102240.1, 102241.1, 10227.1, 102272.1, 102272.2, 102273.1, 102274.1, 102275.1 (Exp 09/12); 102319.1, 102320.1, 102321.1, 102322.1, 102323.1, 102324.1, 102325.1 (Exp 11/12); 102342.1, 102343.1, 102344.1, 102345.1 (Exp 12/12); 112019.1, 112020.1, 112021.1, 112022.1, 112023.1 (Exp 01/13); 112156.1, 112157.1, 112158.1, 112159.1, 112160.1 (Exp 05/13); 112164.1 (Exp 06/13); 112203.1, 112204.1, 112205.1, 112206.1 (Exp 07/13); 112262.1, 112263.1 (Exp 09/13); 112301.1, 112302.1, 112303.1, 112304.1 (Exp 10/13); 112323.1, 112324.1, 112325.1 (Exp 11/13)

The hazard

The product is being recalled due to the discovery of particles in the stability samples and retain samples.

Context

GovInfoNow's records show West-Ward Pharmaceutical Corp. has 23 other recalls on record since 2012-11-30. Other recent recalls of similar products include American Regent Epinephrine Injection Recall (2026-08-11), B. Braun Medical 100mL Sodium Chloride Injection Recall (2026-08-19), and American Regent Papaverine HCl Injection Recall (2026-07-24).

How to tell if you have this one

Check your medication for Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL. Look for NDC numbers 0143-9703-10 (Novaplus) or 0143-9782-10 (West-Ward). Verify the lot number and expiration date against the list provided in the record, such as Lot 112161.1 expiring 05/13 or Lot 102165.2 expiring 05/12.

  • Brand
    West-Ward
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    All lots were distributed throughout the US.
Recall numberProduct, codes & lotsQuantityNDC
D-1437-2012Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).; Lot #s: a) 113153.1, 113154.1, 113155.1, Exp 05/13; 113248.1, Exp 07/13; b) 103196.1, 103197.1, 103197.2, 103198.1, Exp 07/12; 103317.1, 103318.1, 103319.1, 103345.1, 103345.2, Exp 11/12; 103346.1, 103347.1, 103348.1, 103349.1, 103350.1, Exp 12/12; 113030.1, 113031.1, 113032.1, 113033.1, 113034.1, 113035.1, 113036.1, Exp 01/13; 113245.1, 113246.1, 113247.1, Exp 07/13a) 308,275 vials; b) 2,008,850 vials0143-9788-01, 0143-9788-25, 0143-9782-01, 0143-9782-10, 0143-9704-25
D-1438-2012Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10 mL Single Dose Vial, packaged in 10-count x 10 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9703-10), b) West-Ward (NDC 0143-9782-10).; Lot #s: a) 112161.1, 112162.1, 112163.1, Exp 05/13; b) 102165.2, 102167.1, Exp 05/12; 102190.1, 102191.1, 102191.2, 102192.1, 102213.1, Exp 07/12; 102240.1, 102241.1, 10227.1, 102272.1, 102272.2, 102273.1, 102274.1, 102275.1, Exp 09/12; 102319.1, 102320.1, 102321.1, 102322.1, 102323.1, 102324.1, 102325.1, Exp 11/12; 102342.1, 102343.1, 102344.1, 102345.1, Exp 12/12; 112019.1, 112020.1, 112021.1, 112022.1, 112023.1, Exp 01/13; 112156.1, 112157.1, 112158.1, 112159.1, 112160.1, Exp 05/13; 112164.1, Exp 06/13; 112203.1, 112204.1, 112205.1, 112206.1, Exp 07/13; 112262.1, 112263.1, Exp 09/13; 112301.1, 112302.1, 112303.1, 112304.1, Exp 10/13; 112323.1, 112324.1, 112325.1, Exp 11/13a) 74,960 vials; b) 911,070 vials0143-9788-01, 0143-9788-25, 0143-9782-01, 0143-9782-10, 0143-9703-10

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “All lots were distributed throughout the US.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.8 years after the firm started it.

1. Firm started the recall: Apr 13, 201212. FDA classified it Class II: Aug 2, 201223. Published in FDA’s Enforcement Report: Aug 8, 201234. FDA terminated the recall: Jan 16, 2015420122015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Which lot numbers are affected by this recall?

Affected lots include 112161.1, 112162.1, 112163.1, 102165.2, 102167.1, 102190.1, 102191.1, 102191.2, 102192.1, 102213.1, 102240.1, 102241.1, 10227.1, 102272.1, 102272.2, 102273.1, 102274.1, 102275.1, 102319.1, 102320.1, 102321.1, 102322.1, 102323.1, 102324.1, 102325.1, 102342.1, 102343.1, 102344.1, 102345.1, 112019.1, 112020.1, 112021.1, 112022.1, 112023.1, 112156.1, 112157.1, 112158.1, 112159.1, 112160.1, 112164.1, 112203.1, 112204.1, 112205.1, 112206.1, 112262.1, 112263.1, 112301.1, 112302.1, 112303.1, 112304.1, 112323.1, 112324.1, and 112325.1.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1438-2012 (April 13, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1438-2012 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA